Infosys (INFY) filed a counterclaim against Cognizant Technology Solutions (CTSH) in a US court, accusing the company and its Chief Executive Officer Ravi Kumar of anticompetitive tactics, media outlets reported Friday, citing the lawsuit.
Cognizant was alleged to have misused sensitive information to hinder the growth of Infosys' health-care platform and poached key executives, the counterclaim in a Texas federal court said, according to the reports.
Cognizant subsidiary TriZetto had accused Infosys of stealing trade secrets.
Infosys is seeking a jury trial and asking the court to invalidate Cognizant's nondisclosure agreements and award damages, the reports said.
Infosys and Cognizant didn't immediately respond to requests for comments from MT Newswires.
Infosys shares were little changed in recent Friday trading, and Cognizant fell 0.6%
Price: 22.79, Change: +0.01, Percent Change: +0.04
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。